Cancers | Editor’s Choice Articles from 2022–2023 Related to Clinical Research of Cancer

Editor's Choice Articles are selected based on suggestions from Cancers’ Academic Editors worldwide. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are welcome to read the Editor's Choice Articles related to clinical research of cancer, a curated list of high-quality articles from 2023 Cancers (ISSN: 2072-6694). The list of relevant papers can be seen below. The full list of Editor's Choice Articles can be viewed at the following link: https://www.mdpi.com/journal/cancers/editors_choice.

“T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity”
by Nadja Sailer, Ina Fetzer, Melanie Salvermoser, Monika Braun, Doris Brechtefeld, Christian Krendl, Christiane Geiger, Kathrin Mutze, Elfriede Noessner, Dolores J. Schendel et al.
Cancers 2022, 14(8), 1998; https://doi.org/10.3390/cancers14081998
Available online: https://www.mdpi.com/2072-6694/14/8/1998

“Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation”
by Dino Bekric, Matthias Ocker, Christian Mayr, Sebastian Stintzing, Markus Ritter, Tobias Kiesslich and Daniel Neureiter
Cancers 2022, 14(7), 1826; https://doi.org/10.3390/cancers14071826
Available online: https://www.mdpi.com/2072-6694/14/7/1826

“Clinical Viability of Boron Neutron Capture Therapy for Personalized Radiation Treatment”
by Dominika Skwierawska, José Antonio López-Valverde, Marcin Balcerzyk and Antonio Leal
Cancers 2022, 14(12), 2865; https://doi.org/10.3390/cancers14122865
Available online: https://www.mdpi.com/2072-6694/14/12/2865

“Clinical Possibility of Caenorhabditis elegans as a Novel Evaluation Tool for Esophageal Cancer Patients Receiving Chemotherapy: A Prospective Study”
by Yuta Sato, Manabu Futamura, Yoshihiro Tanaka, Hiroshi Tsuchiya, Masahiro Fukada, Toshiya Higashi, Itaru Yasufuku, Ryuichi Asai, Jesse Yu Tajima, Shigeru Kiyama et al.
Cancers 2023, 15(15), 3870; https://doi.org/10.3390/cancers15153870
Available online: https://www.mdpi.com/2072-6694/15/15/3870

“Antibody–Drug Conjugates: A Review of Approved Drugs and Their Clinical Level of Evidence”
by Pooja Gogia, Hamza Ashraf, Sidharth Bhasin and Yiqing Xu
Cancers 2023, 15(15), 3886; https://doi.org/10.3390/cancers15153886
Available online: https://www.mdpi.com/2072-6694/15/15/3886

“Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment”
by Adela Ademaj, Danai P. Veltsista, Pirus Ghadjar, Dietmar Marder, Eva Oberacker, Oliver J. Ott, Peter Wust, Emsad Puric, Roger A. Hälg, Susanne Rogers et al.
Cancers 2022, 14(3), 625; https://doi.org/10.3390/cancers14030625
Available online: https://www.mdpi.com/2072-6694/14/3/625

“Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact”
by Vasileios Vardas, Anastasios Tolios, Athina Christopoulou, Vassilis Georgoulias, Anastasia Xagara, Filippos Koinis, Athanasios Kotsakis and Galatea Kallergi
Cancers 2023, 15(7), 1974; https://doi.org/10.3390/cancers15071974
Available online: https://www.mdpi.com/2072-6694/15/7/1974

“Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy”
by Abhilasha Sinha, Yong Zou, Ayushi S. Patel, Seungyeul Yoo, Feng Jiang, Takashi Sato, Ranran Kong, Hideo Watanabe, Jun Zhu, Pierre P. Massion et al.
Cancers 2022, 14(3), 708; https://doi.org/10.3390/cancers14030708
Available online: https://www.mdpi.com/2072-6694/14/3/708

“Telomerase in Cancer: Function, Regulation, and Clinical Translation”
by Nathaniel J. Robinson and William P. Schiemann
Cancers 2022, 14(3), 808; https://doi.org/10.3390/cancers14030808
Available online: https://www.mdpi.com/2072-6694/14/3/808

“The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications”
by John Charles Rotondo, Chiara Mazziotta, Carmen Lanzillotti, Chiara Stefani, Giada Badiale, Giulia Campione, Fernanda Martini and Mauro Tognon
Cancers 2022, 14(5), 1116; https://doi.org/10.3390/cancers14051116
Available online: https://www.mdpi.com/2072-6694/14/5/1116

“TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer”
by Xiuning Le, Cliff Molife, Mark S. Leusch, Maria Teresa Rizzo, Patrick M. Peterson, Nicola Caria, Yongmei Chen, Elena Gonzalez Gugel and Carla Visseren-Grul
Cancers 2022, 14(24), 6127; https://doi.org/10.3390/cancers14246127
Available online: https://www.mdpi.com/2072-6694/14/24/6127

“Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting”
by Areti Strati, Athina Markou, Evgenia Kyriakopoulou and Evi Lianidou
Cancers 2023, 15(7), 2185; https://doi.org/10.3390/cancers15072185
Available online: https://www.mdpi.com/2072-6694/15/7/2185

“Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials”
by Ignatios Ioakeim-Skoufa, Natalia Tobajas-Ramos, Enrica Menditto, Mercedes Aza-Pascual-Salcedo, Antonio Gimeno-Miguel, Valentina Orlando, Francisca González-Rubio, Ana Fanlo-Villacampa, Carmen Lasala-Aza, Ewelina Ostasz et al.
Cancers 2023, 15(11), 2972; https://doi.org/10.3390/cancers15112972
Available online: https://www.mdpi.com/2072-6694/15/11/2972

“Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study”
by Javier Loscertales, Pau Abrisqueta-Costa, Antonio Gutierrez, José Ángel Hernández-Rivas, Rafael Andreu-Lapiedra, Alba Mora, Carolina Leiva-Farré, María Dolores López-Roda, Ángel Callejo-Mellén, Esther Álvarez-García et al.
Cancers 2023, 15(16), 4047; https://doi.org/10.3390/cancers15164047
Available online: https://www.mdpi.com/2072-6694/15/16/4047

“A Soft Label Deep Learning to Assist Breast Cancer Target Therapy and Thyroid Cancer Diagnosis”
by Ching-Wei Wang, Kuan-Yu Lin, Yi-Jia Lin, Muhammad-Adil Khalil, Kai-Lin Chu and Tai-Kuang Chao
Cancers 2022, 14(21), 5312; https://doi.org/10.3390/cancers14215312
Available online: https://www.mdpi.com/2072-6694/14/21/5312

“Phototheranostics of Cervical Neoplasms with Chlorin e6 Photosensitizer”
by Aida Gilyadova, Anton Ishchenko, Artem Shiryaev, Polina Alekseeva, Kanamat Efendiev, Radmila Karpova, Maxim Loshchenov, Victor Loschenov and Igor Reshetov
Cancers 2022, 14(1), 211; https://doi.org/10.3390/cancers14010211
Available online: https://www.mdpi.com/2072-6694/14/1/211

“The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies”
by Rafael Colmenares, Noemí Álvarez, Santiago Barrio, Joaquín Martínez-López and Rosa Ayala
Cancers 2022, 14(5), 1310; https://doi.org/10.3390/cancers14051310
Available online: https://www.mdpi.com/2072-6694/14/5/1310

“Current and Developing Liquid Biopsy Techniques for Breast Cancer”
by Hsing-Ju Wu and Pei-Yi Chu
Cancers 2022, 14(9), 2052; https://doi.org/10.3390/cancers14092052
Available online: https://www.mdpi.com/2072-6694/14/9/2052